What is the recommended first-line antihypertensive regimen for a 24-year-old Black male with hypertension?

First-Line Antihypertensive for a 24-Year-Old Black Male

For a 24-year-old Black male with hypertension, initiate treatment with either a thiazide-type diuretic (preferably chlorthalidone 12.5-25 mg daily) or a long-acting calcium channel blocker (such as amlodipine), and strongly consider starting with two-drug combination therapy if blood pressure is significantly elevated.

Treatment Algorithm

Step 1: Determine Blood Pressure Severity and Risk

• Stage 1 hypertension (130-139/80-89 mmHg): Start with single-agent therapy 1, 2
• Stage 2 hypertension (≥140/90 mmHg): Start with two-drug combination therapy 3, 1, 2
• If BP is >20/10 mmHg above target: Definitely use combination therapy 1

Step 2: Initial Drug Selection for Black Patients

The evidence consistently shows that ACE inhibitors and ARBs are less effective as monotherapy in Black patients without compelling indications 1, 4. The 2020 ISH guidelines specifically recommend for Black patients 3:

Monotherapy option:

• Low-dose ARB + DHP-CCB, OR
• DHP-CCB + thiazide/thiazide-like diuretic

Preferred combination:

• Thiazide-type diuretic + calcium channel blocker 1, 5

The 2017 ACC/AHA guidelines are explicit: initial therapy should include a thiazide-type diuretic or CCB 1. This is a Class I, Level B-R recommendation.

Step 3: Specific Drug Choices

Thiazide-type diuretic:

• Chlorthalidone 12.5-25 mg daily (preferred for outcomes data) 1
• Hydrochlorothiazide 25-50 mg daily (alternative)

Calcium channel blocker:

• Amlodipine 5-10 mg daily 1
• Other long-acting dihydropyridine CCBs

Step 4: Titration Strategy

1. If starting monotherapy: Increase to full dose, then add second agent from different class 3
2. If starting combination: Titrate both agents to full dose before adding third drug
3. Review and adjust every 2-4 weeks until BP controlled 6
4. Target BP: <130/80 mmHg 3, 1, 2

Critical Evidence Points

The recommendation against ACE inhibitors/ARBs as monotherapy in Black patients is based on:

• Reduced BP-lowering efficacy: Multiple trials show blunted response to RAS inhibitors as monotherapy in Black patients 1, 7
• Outcomes data: Thiazide diuretics are superior to ACE inhibitors for preventing CVD outcomes in Black patients 1
• Combination therapy effectiveness: When combined with diuretics or CCBs, ACE inhibitors/ARBs work equally well in Black patients 8, 9

However, recent evidence questions race-based prescribing 9, 10. The 2025 AHA/ACC guidelines removed race-based drug selection 2, 10, acknowledging that race is a social construct and other factors (volume status, renin levels) may be more relevant.

Important Caveats

Do NOT avoid ACE inhibitors/ARBs if:

• Patient has chronic kidney disease with proteinuria (use ACE inhibitor or ARB regardless of race) 1
• Patient has heart failure with reduced ejection fraction 1
• Patient has diabetes with albuminuria 1

Young age consideration: At 24 years old, this patient will likely need lifelong therapy. Single-pill combinations improve adherence and should be strongly considered 3, 11, 2.

Avoid monotherapy with:

• Beta-blockers (not first-line for uncomplicated hypertension in any age) 12, 13, 14
• Alpha-blockers (not first-line) 12, 13, 14

Practical Implementation

For this specific patient, the most evidence-based approach is:

1. If BP 130-139/80-89 mmHg: Start amlodipine 5 mg daily OR chlorthalidone 12.5 mg daily
2. If BP ≥140/90 mmHg: Start amlodipine 5 mg + chlorthalidone 12.5 mg (preferably as single-pill combination)
3. Recheck BP in 2-4 weeks
4. Titrate to amlodipine 10 mg + chlorthalidone 25 mg if needed
5. Add ARB or ACE inhibitor as third agent if still uncontrolled 3

The combination of CCB + thiazide diuretic addresses the volume-dependent nature of hypertension often seen in Black patients and has strong outcomes data 1.